Nektar Therapeutics(GB:0UNL)
$37.66-0.14 (-0.37%)
GB:0UNL
Nektar Therapeutics ownership
$37.66
At close:-0.14 (-0.37%)
Nektar Therapeutics (0UNL) Ownership - Who Owns Nektar Therapeutics?
0 Followers
Nektar Therapeutics (0UNL) Ownership Overview
- 0.46% Insiders
- 19.38% Mutual Funds
- 30.38% Other Institutional Investors
- 14.20% ETFs
- 35.57% Public Companies and Individual Investors
The ownership structure of Nektar Therapeutics (GB:0UNL) stock is a mix of institutional, retail, and individual investors. Approximately 63.97% of the company’s stock is owned by Institutional Investors, 0.46% is owned by Insiders, and 35.57% is owned by Public Companies and Individual Investors.
The ownership structure of Nektar Therapeutics (GB:0UNL) stock is a mix of institutional, retail, and individual investors. Approximately 63.97% of the company’s stock is owned by Institutional Investors, 0.46% is owned by Insiders, and 35.57% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 19, 2026 | Howard Robin | $30,088 | |
| Aug 19, 2026 | Jonathan Zalevsky | $13,388 | |
| May 20, 2026 | Howard Robin | $29,086 | |
| May 20, 2026 | Jonathan Zalevsky | $13,036 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | $4,397,120 | |
| Dec 31, 2025 | Gilder Gagnon Howe & Co Llc. | $8,807,008 | |
| Dec 31, 2025 | Primecap Management Co | $11,844,742 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 2,871,463 | Institution | 8.41% | 108,139,297 |
| Fidelity Mt. Vernon Street Trust | 2,775,383 | Institution | 8.13% | 104,520,924 |
| Vanguard | 1,798,480 | Institution | 5.27% | 67,730,757 |
| Vanguard Index Funds | 1,462,679 | Institution | 4.28% | 55,084,491 |
| Ishares | 1,329,099 | Institution | 3.89% | 50,053,868 |
| Spdr | 1,144,089 | Institution | 3.35% | 43,086,392 |
| Travis Knapp Anderson | 600,873 | Institution | 1.76% | 22,628,877 |
| Michael Rockefeller | 470,875 | Institution | 1.38% | 17,733,153 |
| Fidelity Salem Street Trust | 415,968 | Institution | 1.22% | 15,665,355 |
| Fidelity Concord Street Trust | 333,696 | Institution | 0.98% | 12,566,991 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 2,775,383 | Institution | 8.13% | 104,520,924 |
| Vanguard Index Funds | 1,462,679 | Institution | 4.28% | 55,084,491 |
| Fidelity Salem Street Trust | 415,968 | Institution | 1.22% | 15,665,355 |
| Fidelity Concord Street Trust | 333,696 | Institution | 0.98% | 12,566,991 |
| Delaware Group Equity Funds Iv | 290,569 | Institution | 0.85% | 10,942,829 |
| Primecap Odyssey Funds | 240,034 | Institution | 0.70% | 9,039,680 |
| Vanguard Scottsdale Funds | 237,390 | Institution | 0.70% | 8,940,107 |
| Schwab Capital Trust | 107,101 | Institution | 0.31% | 4,033,424 |
| Financial Investors Trust | 104,721 | Institution | 0.31% | 3,943,793 |
| Blackrock Funds | 99,150 | Institution | 0.29% | 3,733,989 |
FAQ
Who Owns Nektar Therapeutics (GB:0UNL)?
According to the latest TipRanks data, approximately 63.97% of the company's stock is held by institutional investors, 0.46% is held by insiders, and 35.57% is held by public companies and individual investors.
What percentage of Nektar Therapeutics (GB:0UNL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 63.97% of Nektar Therapeutics (GB:0UNL) stock is held by institutional investors: 19.38% by mutual funds, 14.20% by ETFs and 30.38% by other institutional investors.
What percentage of Nektar Therapeutics (GB:0UNL) stock is held by retail investors?
According to the latest TipRanks data, approximately 35.57% of Nektar Therapeutics (GB:0UNL) stock is held by public companies and individual investors.
Who owns the most shares of Nektar Therapeutics (GB:0UNL)?
BlackRock, Inc. owns the most shares of Nektar Therapeutics (GB:0UNL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
